Give a warm welcome to our new MENA General Manager, Dr. Tamer AbouTaleb!
IGHS Group is strengthening its presence in the Middle East and North Africa markets, this time through its subsidiary INNOV-CELL THERAPEUTICS, which is exclusively focused on the development of innovative biotechnological-based therapeutic solutions in collaboration with several pharmaceutical companies, academic institutions and research & development centers.
Therefore, we are glad to announce that the IGHS Team has been recently joined by Dr. Tamer AbouTaleb, our new MENA General Manager, with more than 22 years of experience in successfully leading, establishing and managing business operations in the Pharmaceuticals, Diagnostics, Consumables, Medical Equipment, Manufacturing and Healthcare domains.
Among several other key positions, Dr. Tamer AbouTaleb was General Manager of United Medical Supplies (UNIMED), Almulla Group – one of the Middle East’s leading healthcare companies, for more than 10 years, and Former Executive Director-Sales at the well-known Al Baker Group. In addition, he has also served in a number of other leading and managerial roles in multinational pharmaceutical companies like GSK, and Schering-Plough.
This relationship plays a key role in the business development of company projects and the strengthening of our market position in the MENA region!
Welcome to the IGHS Team!
-
Innov.Cell ended its successful participation in CPHI 2024
Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.
Read more -
OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)
Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
Read more